NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program

Next-generation sequencing (NGS) is being integrated into routine clinical practice in the field of (hemato-) oncology to search for variants with diagnostic, prognostic, or therapeutic value at potentially low allelic frequencies. The complex sequencing workflows used require careful validation and continuous quality control. Participation in external quality assessments (EQA) helps laboratories evaluate their performance and guarantee the validity of tests results with the ultimate goal of ensuring high-quality patient care. Here, we describe three benchmarking trials performed during the pe... Mehr ...

Verfasser: Thomas Delcourt
Kevin Vanneste
Mohamed Rida Soumali
Wim Coucke
Vanessa Ghislain
Aline Hebrant
Els Van Valckenborgh
Sigrid C. J. De Keersmaecker
Nancy H. Roosens
Philippe Van De Walle
Marc Van Den Bulcke
Aline Antoniou
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: Cancers, Vol 12, Iss 3180, p 3180 (2020)
Verlag/Hrsg.: MDPI AG
Schlagwörter: next-generation sequencing / hemato-oncology / oncology / external quality assessment / cancer / Neoplasms. Tumors. Oncology. Including cancer and carcinogens / RC254-282
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26612469
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/cancers12113180